SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-015489
Filing Date
2021-11-10
Accepted
2021-11-10 16:10:57
Documents
42
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bpth-20210930x10q.htm   iXBRL 10-Q 801204
2 EX-31.1 bpth-20210930xex31d1.htm EX-31.1 12501
3 EX-32 bpth-20210930xex32.htm EX-32 6295
  Complete submission text file 0001558370-21-015489.txt   2475375

Data Files

Seq Description Document Type Size
4 EX-101.SCH bpth-20210930.xsd EX-101.SCH 25335
5 EX-101.CAL bpth-20210930_cal.xml EX-101.CAL 21823
6 EX-101.DEF bpth-20210930_def.xml EX-101.DEF 46405
7 EX-101.LAB bpth-20210930_lab.xml EX-101.LAB 179304
8 EX-101.PRE bpth-20210930_pre.xml EX-101.PRE 141769
9 EXTRACTED XBRL INSTANCE DOCUMENT bpth-20210930x10q_htm.xml XML 215113
Mailing Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401
Business Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401 (832) 742-1357
BIO-PATH HOLDINGS INC (Filer) CIK: 0001133818 (see all company filings)

IRS No.: 870652870 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36333 | Film No.: 211396672
SIC: 2834 Pharmaceutical Preparations